Background
==========

Suicidal behavior (SB) is a leading cause of injury and death worldwide; it accounts for almost one million deaths annually and is the leading cause of death among individuals between 15 and 44 years of age \[[@B1]-[@B3]\]. Suicide has been defined as the act of intentionally ending one's own life. Nonfatal suicidal thoughts and behaviors are classified more specifically into three categories: suicide ideation (refers to thoughts and plans for ending one's life), suicide attempt (engagement in potentially self-injurious behavior with no lethal outcome) and completed suicide (the person ends with his/her life). There are several measurements of past suicidal behavior, which basically consist in predicting future suicidal behavior, as well as to obtain information about history ideation, plans and/or attempts to commit suicide, among other data (e.g. DSM-IV diagnoses) \[[@B4]-[@B6]\].

A genetic influence in SB is now widely acknowledged and has received convincing support from familial, twin and adoption studies \[[@B7],[@B8]\], together with molecular genetic studies mostly conducted on serotonergic candidate genes. Moreover, the evidence from these various genetic studies indicates that dysfunctions of the central serotonergic system are involved in the pathogenesis of suicidal behavior \[[@B9]\]. In this manner, of the several serotonin-related genes studied in relation to SB, one of the most promising is tryptophan hydroxylase (TPH) \[[@B10]\]. The principal reason for testing the association between TPH genes and SB is that TPH is the first and rate-limiting step in the synthesis of the serotonin neurotransmitter \[[@B11]\]. TPH genes have been associated with low CSF 5-HIAA levels in healthy volunteers and have been suggested as a quantitative risk factor, in which a greater effect of the gene results in the intensification of serotonergic dysfunction associated with higher levels of anger and more severe suicidal acts \[[@B12],[@B13]\].

With regard to the TPH enzyme there are two genes encoding it, both lie on intron seven: TPH-1, located on the human chromosome 11p15.3-14, has an approximate length of 29 kb and contains at least 11 exons and TPH-2 on chromosome 12q 21.1 covers a region of about 97 kb and comprises also 11 exons \[[@B14]\]. Thus, variations in TPH genes have prompted several researchers to conduct association genetic studies on TPH single-nucleotide polymorphisms (SNPs) \[[@B15]\]. Of the several different polymorphisms studied, most researches have focused on two SNPs in TPH1 \[[@B16]\]. The first polymorphism, A779C (rs1799913), was identified by single strand conformational analysis and comes mainly in two alternative forms or alleles TPH 779A and TPH 779C, referred to as U and L, respectively \[[@B17]\]. The second polymorphism, A218C (rs1800532), is in complete or strong linkage disequilibrium with A779C in various populations; both have been studied somewhat interchangeably \[[@B9]\]. With regard to TPH2 gene variants, the association with suicidal behavior is in progress and until now several SNPs have been studied \[[@B10]\]. However, the most common SNPS studied in connection with SB are rs4570625 (G-703 T), rs11178997 (A-473 T) and rs1386494 (G19918A) \[[@B18]\]. These SNPs have been selected for their functional relevance. As a result, the G-703 T polymorphism has been reported in higher number in suicidal depressed patients compared with healthy controls, whereas the A-473 T polymorphism has raised large interest for its possible effect on gene expression in the brainstem of depressed patients who committed suicide \[[@B19]\]. Finally, the G19918A polymorphism has been found in association with completed suicides \[[@B20]\].

Although there have been several positive studies associating TPH genes and SB the evidence is inconsistent. These inconclusive results are probably due to small sample sizes, different polymorphic markers used in the analysis, as well as variations in sampling strategies, mainly in the control groups, and the different ethnic populations assessed \[[@B21]\]. Although there are previous meta-analyses \[[@B18],[@B22]-[@B25]\], we decided to undertake another study in which in larger number sample size and more rigorous selection criteria could give us a better understanding into this matter. The aims of the present study were to analyze the association of TPH-1 (A218C and A779C) and TPH2 (G-703 T, A-473 T and G19918A) genes with SB using a meta-analysis and to integrate the outcomes of the several genetic studies included in this methodology by taking into account heterogeneity sources and the evaluation of possible bias in publication. Given that several authors have shown that the frequencies of TPH-1 and TPH-2 gene variants may be ethnic-dependent, we decided to perform a sub-group analysis by populations.

PICOT question
--------------

In population with suicidal behavior, what is the influence of TPH-1 and TPH2 genes variants in manifesting a clinical expression of suicidal behavior when compared to healthy subjects?

Methods
=======

The research protocol of this analysis is available upon request. The meta-analysis and systematic review were performed by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria \[[@B26],[@B27]\].

Identification and selection of publications
--------------------------------------------

Data were obtained by searching in EBSCO and PubMed databases from May to Jun 2013. Relevant publications were identified using the following search terms: "TPH1 and suicidal behavior" (PubMed: 23; EBSCO: 17), "TPH2 and suicidal behavior" (PubMed: 28; EBSCO: 29), "TPH1 and suicide" (PubMed: 25; EBSCO: 17), "TPH2 and suicide" (PubMed: 46; EBSCO: 39), "Tryptophan hydroxylase and suicidal behavior" (PubMed: 90; EBSCO: 53). These words were combined to retrieve the summaries. The search also implicated the review of the bibliography cited at the end of the various research articles. To be selected, the publications had to meet the following criteria: (1) to be published in peer-reviewed journals, (2) to contain independent data, (3) to be case--control association studies in which the frequencies of three genotypes were clearly stated or could be calculated, (4) diagnosis of suicidal behavior of the patients in the study (suicide ideation, suicide attempt and completed suicide), and (5) the use of healthy individuals as controls. A final requirement was that the articles were written in English. The following polymorphisms were studied: A779C (rs1799913) and A218C (rs1800532) of the TPH-1 gene, and rs4570625 (G-703 T), rs11178997 (A-473 T), and rs1386494 (G19918A) of the TPH-2 gene.

Two researchers (González-Castro and Juárez-Rojop) working independently screened each of the titles, abstracts, and full texts to determine inclusion. When the researchers were in disagreement a third researcher (Tovilla-Zárate) was consulted.

Data extraction
---------------

The same authors mentioned above carefully extracted the information from all the included publications. They worked in an independent manner and in accordance with the inclusion criteria listed above. The following data were obtained from each of the studies: authors, year of publication, region, number of cases and controls, age, gender, psychiatric diagnosis, number of males in the groups and ethnical origin of the participants. These data were not always available for all the studies. In the cases of missing data, we contacted the respective authors to ask for the allele frequencies not included in the main text of the papers. One of the studies did not include a control group \[[@B28]\], but we made an adjustment accordingly based on the other studies in the literature that included a control group \[[@B29]\]. Briefly, we calculated the weighted frequency for a particular genotype from studies that included controls and applied it to the study without a control group. We considered the number of the "virtual" control group equal to the number of patients in the specific study. Then the hypothetical number of subjects with the particular genotype frequency was assigned in proportion to the percentage of the same genotype which was obtained from the weighted analysis \[[@B30],[@B31]\]. The outcomes of the meta-analysis were built by taking into consideration the categories reported in previously published studies \[[@B32],[@B33]\].

Figure [1](#F1){ref-type="fig"} shows the stages of the meta-analysis. The combined search included 367 potentially relevant articles. Finally, 37 articles were obtained after discarding overlapping references that did not agree with the inclusion criteria \[[@B16],[@B17],[@B19]-[@B24],[@B28],[@B34]-[@B61]\]; Figure [2](#F2){ref-type="fig"} shows the articles published at this stage of the analysis. In the case of TPH-1 gene variants (A218C and A779C), 5683 cases and 11652 controls were involved, whereas for the TPH-2 gene variants (G-703 T, A-473 T and G19918A) 4196 cases and 5990 controls were considered (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively).

![Flow-chart showing the search strategy and inclusion/exclusion criteria used in the meta-analysis and systematic review.](1471-244X-14-196-1){#F1}

![Distribution of association studies (cases-controls) on TPH genes variants and SB published in PubMed by year.](1471-244X-14-196-2){#F2}

###### 

Descriptive characteristics in association studies on A218C/A779C TPH-1 gene variants and SB by populations

  **Reference**                                      **Location**                                  **Diagnosis**                                        **Number of males**   **Number**   **Genotypes**   **Alleles**   **P for HWE**                                                   
  -------------------------------------------------- --------------------------------------------- ---------------------------------------------------- --------------------- ------------ --------------- ------------- --------------- ---------------- --------- ----------- -------- --------
  ***Caucasian population (A218C TPH-1 variant)***                                                                                                                                                                                                                                       
  Bellivier F. et al., 1998 \[[@B62]\]               France                                        SA and manic-depression                              \-                    57           104             94            34/48/22        11/45/38         116/92    67/121      0.08     0.55
  Geijer T. et al., 2000 \[[@B53]\]                  Sweden                                        SA                                                   57                    64           165             98            30/87/48        13/47/38         147/183   73/123      1.00     0.43
  Du L. et al., 2000 \[[@B54]\]                      Canada                                        SC                                                   \-                    \-           35              84            6/24/5          13/52/19         36/34     78/90       0.04\*   0.04\*
  Souery D. et al., 2001 \[[@B37]\]                  Germany, Greece, Israel, Italy, Sweden, UK.   SI and bipolar disorder                              \-                    \-           167             167           29/85/53        27/74/66         143/191   128/206     0.41     0.75
  Abbar M. et al., 2001 \[[@B47]\]                   France                                        SA                                                   105                   170          231             281           43/120/68       30/133/118       206/256   193/369     0.50     0.30
  Zalsman G.et al., 2001 \[[@B40]\]                  Israel                                        SA                                                   40                    74           84              172           16/34/34        41/85/46         66/102    167/178     0.89     0.17
  Turecki G. et al., 2001 \[[@B39]\]                 Canada                                        SC                                                   \-                    \-           101             129           18/48/35        18/71/40         84/118    107/151     0.15     0.83
  Rujescu D. et al., 2002 \[[@B36]\]                 Germany                                       SA and anger related traits                          27                    66           86              154           10/48/28        19/78/57         68/104    116/192     0.39     0.17
  Rujescu D. et al., 2003 \[[@B24]\]                 Germany                                       SA                                                   52                    \-           147             326           18/81/48        40/155/131       117/177   235/417     0.63     0.08
  Jernej B. et al., 2004 \[[@B34]\]                  Croatia                                       SC                                                   144                   298          185             358           84/85/16        202/141/15       253/117   545/171     0.14     0.49
  Stefulj J. et al., 2005 \[[@B16]\]                 Croatia                                       SC                                                   160                   284          160             284           21/69/70        44/145/95        111/209   233/335     0.39     0.60
  Stefulj J. et al., 2006 \[[@B46]\]                 Croatia                                       SC                                                   247                   320          247             320           33/111/103      50/162/108       177/317   262/378     0.48     0.78
  Viana M.M. et al., 2006 \[[@B48]\]                 Brazil                                        SA, major depression, schizophrenia and alcoholism   142                   36           248             63            45/125/78       7/31/25          215/281   45/81       0.78     0.79
  Baud P. et al., 2009 \[[@B28]\]                    Switzerland, France                           SA                                                   166                   \-           537             1027          99/256/182      181/483/363      454/260   845/1209    0.59     0.34
  Wilson T.et al., 2009 \[[@B52]\]                   USA                                           SA and bipolar disorder                              \-                    39           71              101           13/44/14        22/43/36         70/72     87/115      0.22     0.05\*
  Saetre P. et al., 2010 \[[@B23]\]                  Denmark, Norway, Sweden                       SA and schizophrenia                                 \-                    845          825             1460          289/391/145     570/694/196      969/681   1834/1086   0.00\*   0.63
  Buttenschon H.N. et al., 2013 \[[@B41]\]           Denmark                                       SC                                                   209                   763          490             1027          80/228/182      181/843/363      388/592   845/1209    0.36     0.57
                                                                                                                                                                                                                         868/1884/1131   1469/3282/1754                         0.11     0.37
  ***Asian population (A218C TPH-1 variant)***                                                                                                                                                                                                                                           
  Tsai S.J. et al., 1999 \[[@B55]\]                  Taiwan                                        SA and mood disorders                                \-                    \-           41              200           17/15/9         33/113/54        49/33     179/221     0.06     0.19
  Liu X. et al., 2006 \[[@B56]\]                     China                                         SA                                                   171                   98           287             177           72/148/67       41/84/49         292/282   166/182     0.65     0.63
  Yoon H.K. et al., 2008 \[[@B44]\]                  Korea                                         SA and major depression                              70                    73           193             191           49/97/45        60/85/48         195/187   205/181     0.11     0.88
  Kunugi H. et al.,1999 \[[@B42]\]                   Japan                                         SA                                                   \-                    95           46              208           10/29/7         55/105/48        49/43     215/201     1.00     0.13
  Paik I. et al., 2000 \[[@B45]\]                    Korea                                         SA and schizophrenia                                 \-                    124          27              236           04/12/11        66/116/54        20/34     248/224     0.89     1.00
  Ono H., et al., 2000 \[[@B43]\]                    Japan                                         SC                                                   90                    90           132             132           29/68/35        26/71/35         126/138   123/141     0.38     0.86
  Hong C.J. et al., 2001 \[[@B35]\]                  Taiwan                                        SA and schizophrenia                                 \-                    123          140             251           42/57/41        42/135/74        141/139   219/283     0.15     0.02\*
  Ohtani M. et al., 2004 \[[@B49]\]                  Japan                                         SC                                                   95                    171          134             325           30/60/42        44/113/57        120/144   201/227     0.41     0.37
                                                                                                                                                                                                                         253/486/257     367/822/419                                      
  ***Caucasian population (A779C TPH-1 variant)***                                                                                                                                                                                                                                       
  Nielsen D.A. et al.,1998 \[[@B38]\]                USA                                           SI and alcoholism                                    \-                    232          102             232           17/57/28        49/106/77        91/113    204/260     0.28     0.23
  Rotondo A. et al., 1999 \[[@B51]\]                 Italy and USA                                 SA                                                   \-                    153          97              153           12/50/35        33/68/52         74/120    215/201     0.25     0.51
  Roy A. et al., 2001 \[[@B17]\]                     Sweden                                        SC                                                   \-                    \-           24              158           02/12/20        35/86/37         16/332    156/160     0.33     1.00
  Saetre P. et al., 2010 \[[@B23]\]                  Denmark, Norway and Sweden                    SA and schizophrenia                                 \-                    845          830             1464          290/391/149     570/691/203      971/689   1831/1097   0.00\*   0.63
  Pooley E.C. et al., 2003 \[[@B50]\]                UK                                            SA                                                   52                    138          129             329           20/67/42        44/135/150       107/151   223/435     0.13     0.47
                                                                                                                                                                                                                         341/577/274     731/1086/519                           0.44     0.34
  ***Asian population (A779C TPH-1 variant)***                                                                                                                                                                                                                                           
  Kunugi H. et al., 1999 \[[@B42]\]                  Japan                                         SA                                                   \-                    95           46              208           10/29/7         55/105/48        49/43     215/201     1.00     0.13
  Ohtani M. et al., 2004 \[[@B49]\]                  Japan                                         SC                                                   95                    171          134             325           30/59/42        45/138/82        119/143   228/302     0.38     0.29
  Liu X., et al. 2006 \[[@B56]\]                     China                                         SA                                                   171                   98           266             164           77/126/63       43/85/36         280/252   171/157     0.75     0.46
                                                                                                                                                                                                                         117/214/112     143/328/166                            0.50     0.47

SA = Suicide attempt, SI = Suicide ideation, and SC = Suicide completion.\* Non equilibrium of Hardy Weinberg.

###### 

Descriptive characteristics in association studies on G-703 T/A473T/G19918A TPH-2 gene variants and SB by populations

  **Reference**                                         **Location**   **Diagnosis**             **Number of males**   **Number**   **Genotypes**   **Alleles**   **P for HWE**                                                   
  ----------------------------------------------------- -------------- ------------------------- --------------------- ------------ --------------- ------------- --------------- -------------- -------------- ---------- ------ ------
  ***Caucasian population (G-703 T TPH-2 variant)***                                                                                                                                                                              
  Zhou Z. et al., 2005 \[[@B61]\]                       USA            SA and major depression   150                   196          150             196           106/40/4        132/58/6       252/48         322/70     1.00   1.00
  Zill P. et al., 2007 \[[@B60]\]                       Germany        SA and alcoholism         \-                    164          102             305           61/36/5         191/101/13     158/46         483/127    1.00   1.00
  Stefulj J. et al., 2011 \[[@B57]\]                    Croatia        SC                        291                   280          291             280           181/96/14       183/80/17      458/124        446/114    0.06   0.72
                                                                                                                                                                  348/172/23      506/239/36                               0.78   0.26
  ***Asian population (G-703 T TPH-2 variant)***                                                                                                                                                                                  
  Mouri K. et al., 2009 \[[@B58]\]                      Japan          SC                        156                   162          234             260           62/117/55       80/128/52      241/227        288/232    1.00   1.00
  Yoon H.K. et al., 2008 \[[@B44]\]                     Korea          SA and major depression   82                    80           181             176           58/81/42        34/82/60       197/165        150/202    0.18   0.53
                                                                                                                                                                  120/198/97      114/210/112                              0.37   0.44
  **Reference**                                         **Location**   **Diagnosis**             **Number of males**   **Number**   **Genotypes**   **Alleles**   **P for HWE**                                                   
  **Cases**                                             **Cases**      **Cases**                 **Controls**          **Cases**    **Controls**    **Cases**     **Controls**    **Cases**      **Controls**                     
                                                                                                                                                                  **AA/AT/TT**    **AA/AT/TT**   **A/T**        **A/T**            
  ***Caucasian population (A-473 T TPH-2 variant)***                                                                                                                                                                              
  Zhou Z. et al., 2005 \[[@B61]\]                       USA            SA and major depression   150                   196          150             196           0/14/136        0/15/181       14/286         15/377     1.00   1.00
  Zupanc T.et al., 2011 \[[@B19]\]                      Slovenia       SC and alcoholism         \-                    \-           383             222           0/42/341        2/31/189       42/724         35/409     0.61   0.63
                                                                                                                                                                  0/56/177        2/46/370                                 0.36   0.65
  ***Asian population (A-473 T TPH-2 variant)***                                                                                                                                                                                  
  Mouri K.et al., 2009 \[[@B58]\]                       Japan          SC                        156                   162          234             260           2/44/188        3/48/209       48/420         54/466     1.00   0.74
  **Reference**                                         **Location**   **Diagnosis**             **Number of males**   **Number**   **Genotypes**   **Alleles**   **P for HWE**                                                   
  **Cases**                                             **Cases**      **Cases**                 **Controls**          **Cases**    **Controls**    **Cases**     **Controls**    **Cases**      **Controls**                     
                                                                                                                                                                  **GG/GA/AA**    **GG/GA/AA**   **G/A**        **G/A**            
  ***Caucasian population ( G19918A TPH-2 variant)***                                                                                                                                                                             
  Zill P. et al.,2004 \[[@B20]\]                        Germany        SC                        191                   138          263             266           195/63/5        166/88/12      453/73         420/112    1.00   1.00
  Zill P. et al.,2007 \[[@B60]\]                        Germany        SA and alcoholism         \-                    164          102             305           4/31/67         12/98/195      39/165         122/488    0.75   1.00
  Must A. et al., 2009 \[[@B59]\]                       Estonia        SC                        298                   327          288             327           206/75/7        242/79/6       487/89         563/91     1.00   1.00
  Buttenschon H.N. et al.,2013 \[[@B41]\]               Denmark        SC                        209                   763          553             1033          396/150/7       743/268/22     942/169        1754/312   0.09   0.08
                                                                                                                                                                  801/319/86      1163/533/235                             0.06   0.09
  ***Asian population ( G19918A TPH-2 variant)***                                                                                                                                                                                 
  K. Mouri et al.2009 \[[@B58]\]                        Japan          SC                        156                   162          234             260           219/15/0        239/21/0       453/234        499/260    1.00   1.00

SA = Suicide attempt, SI = Suicide ideation, and SC = Suicide completion.

Data analysis
-------------

For the meta-analysis procedures we used the EPIDAT 3.1 program (<http://www.sergas.es/MostrarContidos_N3_T01.aspx?IdPaxina=62715>). This software is freely available for epidemiologic analysis of tabulated data. Data were analyzed with the random-effects and fixed effects models following the reports in the literature \[[@B63]-[@B65]\]. Sample heterogeneity was analyzed with the Dersimonian and Laird's Q test. Q test results were complemented with graphs to help the visualization of those studies favoring heterogeneity. The studies outside the heterogeneity curve were excluded. The results of the meta-analysis are expressed as odds ratios (ORs). Pooled ORs were calculated respectively for each of the models used, viz.: allelic (Example: A vs. C), additive (AA vs. CC), dominant (AA + AC vs. CC), and recessive (AA vs. AC + CC). Also, we analyzed TPH1 and TPH2 gene variants by Caucasian and Asian populations. To address the problem of publication bias, the Egger's test and funnel plots were calculated with the EPIDAT 3.1 software. This plotting standardizes the effect of each of the published studies on the vertical axis and its correspondent precision on the horizontal axis. Also, we evaluated publication bias using the GRADE approach and assessed the risk for bias. Finally, a chi-squared (χ^2^) analysis was used to calculate the Hardy-Weinberg equilibrium to evaluate genotype distribution. Studies deemed for inclusion in the systematic review were scored for methodological quality using the Newcastle-Ottawa Assessment Scale (NOS). A score of six or more was taken as the cut-off point to distinguish high from low quality studies \[[@B66]\] (see Additional file [1](#S1){ref-type="supplementary-material"}).

Results
=======

We measured the Hardy-Weinberg equilibrium (HWE) in both groups (cases and controls) for all the samples of TPH genes; we also explored all populations in a combined way. Results are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

TPH-1 gene variants
-------------------

### A218C polymorphism

Firstly, an analysis of the variant A218C (rs1800532) of the TPH-1 gene was performed. In this study we evaluated the role of this variant in several models: allelic, additive, dominant and recessive. Also, we considered the Caucasian and Asian populations separately, using the same four models. And as in a previous meta-analysis \[[@B18],[@B22]-[@B25]\], we found a positive association of A218C variant with SB in the fixed effects model, but not in the random effects model. Our results are presented in Table [3](#T3){ref-type="table"}. Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} present the forest plots and Egger's test of the same four models previously mentioned (allelic, additive, dominant and recessive).

###### 

Meta-analysis of case--control studies on A218C/A779C TPH-1 gene variants in patients with suicidal behavior

  **Model analysis**         **A218C**               **P value of Q test**   **P value of Egger's test**   **A779C**   **P value of Q test**   **P value of Egger's test**                                     
  -------------------------- ----------------------- ----------------------- ----------------------------- ----------- ----------------------- ----------------------------- ---------------------- ---------- -------
  **All populations**                                                                                                                                                                                          
  **Allelic**                With heterogeneity      1.10 (0.98-1.22)        **1.09 (1.04-1.16)**          \<0.001     0.85                    0.96 (0.76-1.22)              1.09 (0.99-1.21)       \<0.0001   0.46
  Without heterogeneity      1.02 (0.94-1.11)        1.01 (0.95-1.08)        0.11                          0.27        0.97 (0.85-1.11)        0.97 (0.85-1.11)              0.43                   0.24       
  **Additive**               With heterogeneity      1.22 (0.98-1.52)        **1.22 (1.09-1.37)**          \<0.00001   0.95                    1.02 (0.67-1.54)              **1.29 (1.04-1.59)**   0.001      0.25
  Without heterogeneity      1.06 (0.90-1.24)        1.04 (0.92-1.19)        0.15                          0.50        0.92 (0.71-1.19)        0.92 (0.71-1.19)              0.42                   0.11       
  **Dominant**               With heterogeneity      1.16 (0.96-1.41)        **1.16 (1.07-1.27)**          \<0.0001    0.93                    1.17 (0.75-1.83)              **1.43 (1.21-1.69)**   \<0.0001   0.07
  Without heterogeneity      1.04 (0.91-1.18)        1.02 (0.93-1.13)        0.07                          0.65        1.00 (0.82-1.22)        1.00 (0.82-1.22)              0.47                   0.73       
  **Recessive**              With heterogeneity      1.10 (0.94-1.28)        1.04 (0.95-1.15)              0.0005      0.15                                                                                     
  Without heterogeneity      0.97 (0.87-1.08)        0.97 (0.87-1.08)        0.97                          0.80        0.88 (0.72-1.08)        0.90 (0.76-1.06)              0.23                   0.23       
  **Caucasian population**                                                                                                                                                                                     
  **Allelic**                With heterogeneity      1.12 (0.971.29)         1.10 (1.04-1.17)              \<0.0001    0.69                    0.90(0.62-1.30)               1.11(0.98 1.25)        \<0.0001   0.60
                             Without heterogeneity   1.01(0.91-1.13)         1.00 (0.93-1.08)              0.006       0.36                    0.95(0.78-1.14)               0.95(0.78 1.14)        0.58       0.25
  **Additive**               With heterogeneity      1.25 (0.95-1.64)        1.22 (1.07-1.39)              \<0.0001    0.73                    0.89(0.46-1.71)               1.36 (1.05 1.75)       \<0.0001   0.80
                             Without heterogeneity   1.05(0.87-1.27)         1.03 (0.88-1.19)              0.18        0.22                    0.80(0.55-1.16)               0.80(0.55-1.16)        0.69       0.94
  **Dominant**               With heterogeneity      1.24(0.96-1.59)         1.20 (1.09-1.32)              \<0.0001    0.68                    1.17(0.75-1.83)               1.43(1.21-1.69)        \<0.0001   0.40
                             Without heterogeneity   1.12(0.97-1.28)         1.10 (0.97-1.25)              0.35        0.06                    1.09(0.83-1.44)               1.09(0.83 -1.44)       0.77       0.58
  **Recessive**              With heterogeneity      1.02 (0.841.24)         0.97 (0.87-1.09)              \<0.0001    0.34                    0.81(0.67-0.98)               0.81(0.670.98)         \<0.0001   0.30
                             Without heterogeneity   0.95 (0.84-1.06)        0.95 (0.84-1.06)              0.66        0.20                    0.68(0.51-0.91)               68(0.51-0.91)          0.71       0.31
  **Asian population**                                                                                                                                                                                         
  **Allelic**                With heterogeneity      1.06(0.89-1.27)         1.06 (0.94-1.20)              0.04        0.72                    1.05(0.88 1.27)               1.05(0.88-1.27)        0.93       0.84
                             Without heterogeneity   1.11(0.95-1.28)         1.10 (0.97 1.24)              0.21        0.30                                                                                     
  **Additive**               With heterogeneity                                                                                                                                                                 
                             Without heterogeneity   1.17(0.83-1.65)         1.18 (0.93 1.50)              0.06        0.69                    1.15(0.79-1.68)               1.15(0.79-1.68)        0.83       0.76
  **Dominant**               With heterogeneity                                                                                                0.99(0.73-1.35)               0.99(0.73-1.35)        0.45       0.10
                             Without heterogeneity   1.01(0.82-1.25)         1.01(0.84-1.23)               0.31        0.27                    0.92(0.67.1.28)               0.92(0.67-1.28)        0.88       1.000
  **Recessive**              With heterogeneity      1.18(0.81-1.72)         1.19(0.97-1.45)               0.002       0.89                    1.16(0.86-1.58)               1.16(0.86-1.58)        0.40       0.54
                             Without heterogeneity   0.94(0.74-1.18)         0.94 (0.74-1.18)              0.52        0.27                                                                                     

Bold text: Statistically significant.

![Odds ratios and forest plots of A218C in overall studies without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-3){#F3}

![Egger's funnel plots indicating publication bias in studies on suicidal behavior and the A218C variant without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive models.](1471-244X-14-196-4){#F4}

### A779C polymorphism

With this variant we conducted the same analyses than in the previous variant gene (A218C). We observed a significant association with suicidal behavior, using the fixed effects model. This analysis was extended to Caucasian and Asian populations treated separately. Table [3](#T3){ref-type="table"} shows in more detail the analysis of this variant gene in all the models tested (allelic, additive, recessive and dominant). Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"} present forest plots and Egger's tests in the same models.

![Odds ratios and forest plots of A779C in overall studies without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-5){#F5}

![Egger's funnel plots indicating publications bias in studies on suicidal behavior and the A779C variant without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive models.](1471-244X-14-196-6){#F6}

TPH-2 gene variants
-------------------

### G703T polymorphism

The first variant analyzed was the G-703 T (rs4570625) polymorphism. Initially, we explored the association of the G allele and patients with SB; we did not find significant differences (Random effects: OR: 1.02; 95% CI 0.85-1.22; p(Z) =0.99). We observed heterogeneity in all studies (Q = 12.43; df = 6; p = 0.04). The Egger\'s test provided no evidence of publication bias (t = 0.04; df = 5; p = 0.96) (see Additional file [1](#S1){ref-type="supplementary-material"}). Next, we excluded the study by Yoon and Kim \[[@B44]\], based on heterogeneity, and still we could not find any significant differences (Random effects: OR: 0.93; 95% CI 0.81-1.06; p(Z) =0.70; Figure [7](#F7){ref-type="fig"}A; Q test = 1.73; df = 5; p = 0.88). Also, there was no evidence of publication bias (Egger's test: t = 1.01, df = 4; p = 0.36; Figure [8](#F8){ref-type="fig"}A). The same results were found when we used the additive model without heterogeneity (Random effects: OR: 0.88; 95% CI 0.65-1.20; p(Z) =0.45; Figure [7](#F7){ref-type="fig"}B; Q test = 1.65; df = 6; p = 0.89). No evidence of publication bias was encountered (Egger's test t = 1.03; df = 5; p = 0.36; Figure [8](#F8){ref-type="fig"}B). We did not find any significant differences when we used the dominant model without heterogeneity either (Random effects: OR: 1.07; 95% CI 0.84-1.38; p(Z) =0.76; Figure [7](#F7){ref-type="fig"}C; Q test = 6.43; df = 6; p = 0.37). Similarly, no evidence of publication bias was observed (Egger's test: t = 0.24, df = 5; p = 0.83; Figure [8](#F8){ref-type="fig"}). Finally, the same negative results were found in the recessive model without heterogeneity (Random effects: OR: 0.91; 95% CI 0.76-1.09; p(Z) =0.45; Q test = 1.76; df = 6; p = 0.88; Figure [7](#F7){ref-type="fig"}D). No evidence of publication bias was encountered (Egger's test: t = 0.46; df = 5; p = 0.66; Figure [8](#F8){ref-type="fig"}D). In addition, we conducted the same analyses using the allelic, additive, dominant and recessive models in Asian and Caucasian populations, separately. However, we could not find any significant differences (Table [4](#T4){ref-type="table"}).

![Odds ratios and forest plots of the G-703 T TPH-2 variant in overall studies without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-7){#F7}

![Egger\'s funnel plots indicating publication bias in studies on suicidal behavior and the G-703 T TPH-2 variant without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-8){#F8}

###### 

Meta-analysis of case--control studies on G-703 T/ A-473 T/G19918A TPH-2 gene variants and SB by populations

  **Model analysis**         **G703T**               **P value of Q test**   **P value of Egger's test**   **A473T**   **P value of Q test**   **P value of Egger's test**   **G19918A**                                                                
  -------------------------- ----------------------- ----------------------- ----------------------------- ----------- ----------------------- ----------------------------- ----------------- ------ ------ ----------------- ----------------- ------ ------
  **Caucasian population**                                                                                                                                                                                                                              
  **Allelic**                With heterogeneity      0.95(0.79-1.14)         0.95(0.79-1.14)               0.91        0.72                    0.95(0.79-1.14)               0.95(0.79-1.14)   0.91   0.72   1.12(0.88-1.43)   1.09(0.95-1.25)   0.04   0.59
                             Without heterogeneity                                                                                                                                                           0.99(0.85-1.16)   0.99(0.851.16)    0.52   0.57
  **Additive**               With heterogeneity      1.03(0.66-1.62)         1.03(0.6-61.62)               0.84        0.56                    1.03(0.66-1.62)               1.03(0.66-1.62)   0.84   0.56   1.45(0.87-2.40)   1.45(0.87-2.40)   0.44   0.95
                             Without heterogeneity                                                                                                                                                                                                       
  **Dominant**               With heterogeneity      1.05(0.68-1.62)         1.05(0.68-1.62)               0.79        0.79                    1.05(0.68-1.62)               1.05(0.68-1.62)   0.79   0.79   1.18(0.79-1.76)   1.14(0.80-1.64)   0.35   0.33
                             Without heterogeneity                                                                                                                                                                                                       
  **Recessive**              With heterogeneity      0.91(0.72-1.15)         0.91(0.72-1.15)               0.86        0.54                    0.91(0.72-1.15)               0.91(0.72-1.15)   0.86   0.54   1.15(0.86-1.55)   1.09(0.93-1.29)   0.06   0.59
                             Without heterogeneity                                                                                                                                                           0.98(0.81-1.18)   0.98(0.81-1.18)   0.60   0.52
  **Asian population**                                                                                                                                                                                                                                  
  **Allelic**                With heterogeneity      1.08(0.78-1.50)         1.08(0.92-1.27)               0.01        0.93                                                                                                                             
                             Without heterogeneity   0.91(0.75-1.11)         0.91(0.75-1.11)               0.47        0.58                                                                                                                             
  **Additive**               With heterogeneity      1.14(0.57-2.27)         1.14(0.81-1.60)               0.01        0.99                                                                                                                             
                             Without heterogeneity   0.78(0.51-1.17)         0.78(0.511.17)                0.78        0.29                                                                                                                             
  **Dominant**               With heterogeneity      1.09(0.82-1.44)         1.09(0.82-1.44)               0.11        0.94                                                                                                                             
                             Without heterogeneity                                                                                                                                                                                                      
  **Recessive**              With heterogeneity      1.13 (0.74-1.70)        1.11(0.87-1.41)               0.03        0.86                                                                                                                             
                             Without heterogeneity   0.93(0.70-1.22)         0.93(0.70-1.22)               0.48        0.94                                                                                                                             

### A473T polymorphism

Also, we conducted an analysis of allele A of the A-473 T (rs11178997) polymorphism in association with SB and we found the same negative results with heterogeneity (Random effects: OR: 0.89; 95% CI 0.63-1.26; p(Z) =0.98; Q test = 18.81 df = 5; p = 0.002). No evidence of publication bias was found (Egger's test t = 0.83, df = 4; p = 0.44). Next, we eliminated heterogeneity by excluding the study by Zhou et al. \[[@B61]\] in a Caucasian population (Random effects: OR:0.76; 95% CI 0.61-0.95; p(Z) =0.80; Q test = 4.54; df = 4; p = 0.33; Figure [9](#F9){ref-type="fig"}A) and found no significant differences. Besides, we did not encounter evidence of publication bias (Egger's test: t = 1.04; df = 3; p = 0.37; Figure [10](#F10){ref-type="fig"}A). When we used the additive model, we excluded the studies by Zupanc et al. \[[@B19]\] and Zhou et al. \[[@B61]\] in the Caucasian population given that some frequencies were equal to zero. Still, we did not find any significant differences without heterogeneity (Random effects: OR: 1.00; 95% CI 0.52-1.93; p(Z) =0.73; Figure [9](#F9){ref-type="fig"}B; Q test = 2.91; df = 3; p = 0.40); also we did not encounter evidence of publication bias (Egger's test: t = 0.36, df = 2; p = 0.74; Figure [10](#F10){ref-type="fig"}B). A negative result was also found for the dominant model without heterogeneity (Random effects: OR: 1.01; 95% CI 0.76-1.34; p(Z) =0.70; Figure [9](#F9){ref-type="fig"}C; Q test = 10.46; df = 5; p = 0.06); no evidence of publication bias was encountered (Egger's test: t = 1.74; df = 4; p = 0.15; Figure [10](#F10){ref-type="fig"}C). The same negative results were obtained with the recessive model without heterogeneity excluding the studies by Zupanc et al. \[[@B19]\] and Zhou et al. \[[@B61]\] in the Caucasian population because some frequencies were equal to zero (Random effects: OR:1.01; 95% CI 0.53-1.93; p(Z) =0.73; Figure [9](#F9){ref-type="fig"}D; Q test = 2.33; df = 3; p = 0.50); there was no evidence of publication bias (Egger's test: t = 0.31; df = 2; p = 0.78; Figure [10](#F10){ref-type="fig"}D). In addition, with regard to the analysis of the A-473 T variant of the TPH-2 gene in relation to SB, we conducted an analysis in the Caucasian population, using the same four models as above and could not find any significant differences (Table [4](#T4){ref-type="table"}).

![Odds ratios and forest plots of the A-473 T TPH-2 variant in overall studies without heterogeneity using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-9){#F9}

![Egger\'s funnel plots indicating publication bias in studies on suicidal behavior and the A-473 T TPH-2 variant without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-10){#F10}

### G19918A polymorphism

Finally, the G19918A (rs1386494) polymorphism was the last variant studied in association with SB. When we analyzed allele G vs allele A, we could not find any significant differences in the analysis without heterogeneity (Random effects: OR: 1.09; 95% CI 0.91-1.31; p(Z) =0.98; Figure [11](#F11){ref-type="fig"}A; Q test = 10.32; df = 5; p = 0.06); we found no evidence of publication bias (Egger's test: t = 0.78; df = 4; p = 0.47; Figure [12](#F12){ref-type="fig"}A). Subsequently, we performed an analysis with the additive model without heterogeneity (Random effects: OR: 1.45; 95% CI 0.87-2.40; p(Z) =0.80; Figure [11](#F11){ref-type="fig"}B; Q test = 3.70; df = 4; p = 0.44); we found no evidence of publication bias (Egger's test: t = 0.09; df = 3; p = 0.95, Figure [12](#F12){ref-type="fig"}B). The same negative outcome was found when using the dominant model without heterogeneity (Random effects: OR: 1.18; 95% CI 0.79-1.76; p(Z) =0.80; Figure [11](#F11){ref-type="fig"}C; Q test = 4.38; df = 4; p = 0.35); no evidence of publication bias was found (Egger's test: t = 1.14; df = 3; p = 0.33; Figure [12](#F12){ref-type="fig"}C). The same result was obtained with the recessive model without heterogeneity (Random effects: OR: 1.16; 95% CI 0.90-1.50; p(Z) =0.45; Figure [11](#F11){ref-type="fig"}D; Q test = 9.12; df = 5; p = 0.10); no evidence of publication bias was encountered (Egger's test: t = 0.74; df = 4; p = 0.49; Figure [12](#F12){ref-type="fig"}D). Finally, we conducted an analysis in the Caucasian population separately using the same four models as in the other polymorphism, and could not find any significant differences (Table [4](#T4){ref-type="table"}).

![Odds ratios and forest plots of the G19918A TPH-2 variant in overall studies without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-11){#F11}

![Egger\'s funnel plots indicating publication bias in studies on suicidal behavior and the G19918A TPH-2 variant without heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.](1471-244X-14-196-12){#F12}

Discussion
==========

In this study, we explored the association of THP-1 and TPH-2 gene polymorphisms with suicidal behavioral. We found an association between A218C/ATT9C polymorphism of TPH1 and suicidal behavior. However, we could not find an association between TPH2 gene variants and this behavior. To our knowledge, this is the first study evaluating TPH2 gene variants and suicidal behavior.

Suicide has become a serious problem around the world. Various published studies show the search for possible genetic markers that could help in the early detection and prevention of suicidal behavior \[[@B13],[@B67],[@B68]\]. One possible mechanism by which genetic factors may affect the risk for suicide is through the control of serotonergic neurotransmission. TPH genes have been proposed as the main candidate genes in association studies on suicidal behavior, given that the TPH enzyme is a rate-limiting step in serotonin biosynthesis. Despite the increasing amount of genetic association studies on SB, the results are inconclusive. Therefore, we performed a meta-analysis in order to evaluate the association of TPH-1 and TPH-2 genes with SB in which we integrated the outcomes of the different polymorphic markers and different ethnic groups. Initially, although variants A218C (rs1800532) and A779C (rs1799913) of the TPH-1 gene have been studied in relation to suicidal behavior in different meta-analyses \[[@B18],[@B22]-[@B25]\], we analyzed the TPH-1 gene in patients with SB. The evaluated variants of this gene were A779C (rs1799913) and A218C (rs1800532); these two polymorphisms are the most studied of the TPH-1 gene and with interesting outcomes. We not only analyzed allele A vs allele C, but also evaluated the association using three other models: additive, dominant and recessive in a pool population that combined the genetic studies of TPH-1 variants. In addition, we performed a sub-group analysis in Caucasian and Asian populations separately to evaluate the association of A779C (rs1799913) and A218C (rs1800532) polymorphisms with SB using the same four models. Our results are in agreement with previous meta-analyses \[[@B18],[@B22]-[@B25]\]. These studies report a strong association with SB using the fixed effects model. In the present meta-analysis we also found an association when we used the fixed effects model, but not with the random effects model. However, this result should be taken with caution because the random effects model is more conservative than the fixed effects one. The latter assumes the same true genetic effects, and the former supposes normally distributed effects and parametrizes inter-studies variations. To get a clearer panorama of the possible role of these variants in SB, we summarized the results of our analyses in Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}. The evidence suggests that TPH-1 A218C/A779C polymorphisms may be associated with increased susceptibility to present SB clinically.

On the other hand, to explore the association of SB with TPH-2 gene, we chose rs4570625 (G-703 T), rs11178997 (A-473 T) and rs1386494 (G19918A) variants, given their functionality and the extensive amount of studies evaluating these polymorphisms in association with SB. We performed the analysis with the same four models used for the TPH1-gene: allelic, additive, dominant, and recessive. We also conducted a sub-group analysis in the Caucasian and Asian populations utilizing the same previously mentioned models. In the present study we could not find any association in any of the models, but we found a slight protective effect concerning polymorphism A-473 T toward suicidal behavior in the recessive model (Random effects: OR: 0.76; 95% CI 0.61-0.95; p(Z) =0.80; Q test = 4.54; df = 4; p = 0.33); no evidence of publication bias was encountered (Egger's test: t = 1.04; df = 3; p = 0.37).

There are several explanations for the present outcomes concerning the lack of association of TPH-2 variants with SB. First, the criteria used in the selection of the control groups differ among studies. Second, although the subjects were patients with SB, there were differences in the diagnoses (attempted, ideation and completed suicide, and exclusion criteria of neuropsychiatric diseases, among other factors). For example, Souery et al. \[[@B37]\] work with patients with bipolar disorder that present SB, Yoon and Kim \[[@B44]\] with depressive subjects and SB, Paik et al. \[[@B45]\] with schizophrenic patients, and Turecki et al. \[[@B39]\] with suicide completers only. Other possibility is genetic heterogeneity: some authors have shown that the distribution of the frequencies of TPH-2 variants may depend on ethnicity. Therefore, we evaluated the association of TPH2 variants with SB in several populations. The fourth explanation considers the presence of other genes which may interact with TPH-2 to increase the risk to present SB clinically. We also want to emphasize the relevance of employing larger sample sizes to enable the observation of more conclusive results.

This study has some limitations. First, we performed the present meta-analysis based only on published studies. We considered that by selecting only published results, we ensured that our meta-analysis excluded poorly designed studies. Second, although the present analysis involves a large number of studies and genetic variants, it is relatively small in comparison with other meta-analysis on different diseases. Also, we could not perform an analysis including suicide ideation, suicide attempt, or completed suicide. Other limitation is that we did not stratify the analysis by gender because it was not always possible to obtain all the data from the reports or directly from the authors. Also, we did not perform the analysis of all the variants of the TPH-2 gene in the Asian population because there were not enough studies. Sixth, we did not evaluate SB endophenotypes or psychopathologies which could increase the risk for suicidal behavior. One last comment: is that although there are previous meta-analyses evaluating the association of the TPH-1 gene (A218C and A779C variants) and SB, our study contains more recent data and the use of various types of models to perform the analysis.

Conclusion
==========

In summary, we performed a meta-analysis to assess the association of A779C (rs1799913) and A218C (rs1800532) variants of the TPH-1 gene, and rs4570625 (G-703 T), rs11178997 (A-473 T), and rs1386494 (G19918A) of the TPH-2 gene with SB. Our analysis of TPH-1 provided evidence that A218C/A779C TPH-1 variants may be risk factors to present SB, which is in agreement with previously reported meta-analyses \[[@B18],[@B22]-[@B25]\]. With regard to G-703 T/A-473 T/G19918A TPH-2 variants, our updated meta-analysis did not detect any significant association with patients presenting SB. However, these results should be interpreted with caution because not all the models detected this association and the sample size may be just enough to detect small effects of the polymorphisms. Further studies with larger samples in different ethnic populations need to be undertaken to confirm our findings.
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